IQVIA Laboratories Launches Site Lab Navigator to Transform Clinical Trials with e-Requisition Innovation
IQVIA Laboratories, a global leader in drug discovery and development laboratory services, has unveiled its Site Lab Navigator — an advanced suite of solutions designed to automate and streamline laboratory workflows for clinical trial sponsors and investigator sites. This innovative technology promises to reduce administrative burdens, minimize errors, and improve study execution, transforming the clinical trial process for sponsors and sites alike.
Revolutionizing Clinical Trials with e-Requisition Technology
At the core of Site Lab Navigator is the groundbreaking e-Requisition solution, which enables investigator sites to electronically submit requisitions and manage lab specimens. This eliminates the need for manual, paper-based processes, addressing a critical pain point in clinical trials. By automating these key workflows, the solution drives compliance, reduces human errors, and significantly improves efficiency, ultimately leading to enhanced clinical trial outcomes.
The e-Requisition solution is a one-of-a-kind technology within the Site Lab Navigator suite. Unlike other requisitioning solutions on the market, it offers features and capabilities that enhance operational efficiency and data integrity.
Key Features of Site Lab Navigator’s e-Requisition Solution
- Seamless Portal Integration
The solution provides easy access through IQVIA’s One Home for Sites™ single sign-on. This integration simplifies the process for users, allowing investigator sites to quickly navigate and manage all requisitioning tasks from a single platform. - Real-Time Sample Tracking
With end-to-end shipping visibility powered by courier data, investigator sites and sponsors can track samples in real time. This ensures better management of samples and improved transparency across the trial process. - Guided Kit Replacement
The solution includes online kit order management to minimize waste and ensure that sites receive the correct materials at the right time, reducing unnecessary costs and delays. - Real-Time Data Validation
Real-time data validation enhances the accuracy of trial data and accelerates reporting times, enabling faster decision-making and more efficient trial progression. - Guided Data Entry
By eliminating data recording errors, the e-Requisition solution significantly reduces visit queries, streamlines patient reporting, and expedites database locks, making the process smoother and more efficient. - Online Sample Collection Guidance
The solution simplifies workflows by offering step-by-step guidance for sample collection. This ensures sites stay compliant with trial protocols while reducing the administrative burden on clinical staff.
Improving Clinical Trial Execution
The launch of Site Lab Navigator and its e-Requisition solution comes at a crucial time for the clinical trial industry, where efficiency and data integrity are paramount. By automating labor-intensive processes, IQVIA Laboratories is empowering investigator sites with the tools they need to manage clinical trials more effectively.
David Morris, Chief Operating Officer at IQVIA Laboratories, commented, “Site Lab Navigator and its differentiated e-Requisition solution will significantly reduce administrative burden on sites and improve the quality and execution of clinical trials for our customers. The early response has been extremely positive, with a number of sponsors already signed on, including several top 10 pharmaceutical companies. By equipping investigator sites with cutting-edge tools, we are streamlining workflows, improving data integrity, and ultimately accelerating the path to high-quality results.”
The positive reception from clinical trial sponsors underscores the value of this technology in improving the clinical trial process. With Site Lab Navigator, trial sponsors and investigator sites can expect to see faster and more accurate results, with reduced risk of delays and errors.
The Future of Clinical Trial Operations
IQVIA Laboratories’ Site Lab Navigator is a significant step toward the future of clinical trial management. By offering automation, real-time data validation, and an intuitive user experience, the solution enhances trial efficiency and ensures high-quality outcomes. As the industry moves toward greater digitalization, the e-Requisition solution serves as an example of how technology can streamline workflows and improve trial execution from start to finish.
This innovative suite of tools underscores IQVIA’s commitment to delivering site-centric solutions that not only meet the needs of clinical trial sponsors but also empower investigator sites with the tools they need to succeed. The result is a faster, more accurate, and efficient path to clinical trial success — a win for all stakeholders involved.
Conclusion: A New Era for Clinical Trials
IQVIA Laboratories is redefining how clinical trials are managed by introducing cutting-edge solutions like Site Lab Navigator and its e-Requisition technology. This innovative platform simplifies workflows, improves compliance, and enhances data integrity, providing clinical trial sponsors and investigator sites with the tools they need to deliver high-quality results faster. As the clinical trial industry continues to evolve, IQVIA’s commitment to transforming the process through automation and digital innovation will undoubtedly play a pivotal role in advancing drug development and patient care.
For more information about Site Lab Navigator and e-Requisition, visit www.labs.iqvia.com/investigator-support.
About IQVIA Laboratories
IQVIA Laboratories is a leading global drug discovery and development laboratory services organization offering a comprehensive suite of central laboratory and specialty biomarker services. Our expertise spans central laboratory, genomics, immunoassays, flow cytometry, anatomic pathology, precision medicine, vaccine, ADME, and bioanalytical services. IQVIA Laboratories also brings extensive expertise in antibody drug discovery, biomarker discovery, and decentralized clinical trial laboratory solutions.
With a commitment to scientific excellence and operational efficiency, IQVIA Laboratories supports the entire drug development lifecycle across diverse regions and regulatory landscapes, ensuring data integrity and optimizing research to bring life-changing therapies to patients faster. To learn more visit www.labs.iqvia.com.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry.
With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
